A review of therapeutic agents for the management of pulmonary arterial hypertension

被引：10

作者：

Hahn, Stella S. ^{[1
]}

Makaryus, Mina ^{[1
]}

Talwar, Arunabh ^{[1
]}

Narasimhan, Mangala ^{[1
]}

Zaidi, Gulrukh ^{[1
]}

机构：

[1] Northwell Hlth, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 11042 USA

来源：

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2017年 / 11卷 / 01期

关键词：

pulmonary arterial hypertension; prostanoid; endothelin receptor antagonist; phosphodiesterase inhibitor; soluble guanylate cyclase stimulator; ENDOTHELIN RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; CONTINUOUS INTRAVENOUS EPOPROSTENOL; NITRIC-OXIDE SYNTHASE; 5 INHIBITOR THERAPY; DOUBLE-BLIND; INHALED ILOPROST; ORAL TREPROSTINIL; COMBINATION THERAPY; PROSTACYCLIN ANALOG;

D O I：

10.1177/1753465816665289

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening disease characterized by a proliferative vasculopathy of the small muscular pulmonary arterioles resulting in elevated pulmonary vascular resistance and eventually right ventricular failure. An increasing understanding of the pathobiology of PAH and its natural history has led to the development of numerous targeted therapies. Despite these advances there is significant progression of disease and the survival rate remains low. This article reviews the agents currently available for the medical management of PAH.

引用

页码：46 / 63

页数：18

共 50 条

[1] Pulmonary Arterial Hypertension and Therapeutic Interventions
Gabra, Nader B. Ishak
Mahmoud, Omar
Ishikawa, Oki
Shah, Varun
Altshul, Erica
Oron, Maly
Mina, Bushra
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2019, 28 (02) : 80 - 92
[2] The limits of oral therapy in pulmonary arterial hypertension management
Liu, Qian-Qian
Jing, Zhi-Cheng
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1731 - 1741
[3] Pharmacotherapeutic Management of Pulmonary Arterial Hypertension
Anderson, Joe R.
Nawarskas, James J.
CARDIOLOGY IN REVIEW, 2010, 18 (03) : 148 - 162
[4] Management of Pulmonary Arterial Hypertension
McLaughlin, Vallerie V.
Shah, Sanjiv J.
Souza, Rogerio
Humbert, Marc
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (18) : 1976 - 1997
[5] Management of Pulmonary Arterial Hypertension
Mayeux, Jennalyn D.
Pan, Irene Z.
Dechand, John
Jacobs, Joshua A.
Jones, Tara L.
McKellar, Stephen H.
Beck, Emily
Hatton, Nathan D.
Ryan, John J.
CURRENT CARDIOVASCULAR RISK REPORTS, 2021, 15 (01)
[6] Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension A Meta-analysis of Randomized Controlled Trials
Liu, Huan-long
Chen, Xue-yan
Li, Jie-ru
Su, Su-wen
Ding, Tao
Shi, Chen-xia
Jiang, Yun-fa
Zhu, Zhong-ning
CHEST, 2016, 150 (02) : 353 - 366
[7] Current management of pulmonary arterial hypertension
Yerly, Patrick
Prella, Maura
Aubert, John-David
SWISS MEDICAL WEEKLY, 2016, 146 : w14305
[8] The prostacyclin pathway in pulmonary arterial hypertension: a clinical review
Del Pozo, R.
Hernandez Gonzalez, I.
Escribano-Subias, P.
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (06) : 491 - 503
[9] Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, Marc
Lau, Edmund M. T.
Montani, David
Jais, Xavier
Sitbon, Oliver
Simonneau, Gerald
CIRCULATION, 2014, 130 (24) : 2189 - 2208
[10] Management of Pulmonary Arterial Hypertension
Weatherald, Jason
Varughese, Rhea A.
Liu, Jonathan
Humbert, Marc
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (06) : 746 - 761

← 1 2 3 4 5 →